These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23620560)

  • 1. Progression of structural damage is not related to rituximab serum levels in rheumatoid arthritis patients.
    Boumans M; Teng O; Thurlings R; Bijlsma J; Gerlag D; Huizinga T; Vos K; Stapel S; Wolbink G; Tekstra J; van Laar J; Tak PP
    Rheumatology (Oxford); 2013 Aug; 52(8):1462-6. PubMed ID: 23620560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of radiographic scoring methods in a cohort of RA patients treated with anti-TNF therapy.
    Barnabe C; Hazlewood G; Barr S; Martin L
    Rheumatology (Oxford); 2012 May; 51(5):878-81. PubMed ID: 22223704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis.
    Boumans MJ; Thurlings RM; Yeo L; Scheel-Toellner D; Vos K; Gerlag DM; Tak PP
    Ann Rheum Dis; 2012 Jan; 71(1):108-13. PubMed ID: 22072013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of three radiologic scoring systems for the long-term assessment of rheumatoid arthritis: findings of an ongoing prospective inception cohort study of 132 women followed up for a median of twelve years.
    Drossaers-Bakker KW; Amesz E; Zwinderman AH; Breedveld FC; Hazes JM
    Arthritis Rheum; 2000 Jul; 43(7):1465-72. PubMed ID: 10902747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating joint destruction in rheumatoid arthritis: is it necessary to radiograph both hands and feet?
    Knevel R; Kwok KY; de Rooy DP; Posthumus MD; Huizinga TW; Brouwer E; van der Helm-van Mil AH
    Ann Rheum Dis; 2013 Mar; 72(3):345-9. PubMed ID: 22580587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of CXCL13 as a marker for rheumatoid arthritis outcome using an in silico model of the rheumatic joint.
    Meeuwisse CM; van der Linden MP; Rullmann TA; Allaart CF; Nelissen R; Huizinga TW; Garritsen A; Toes RE; van Schaik R; van der Helm-van Mil AH
    Arthritis Rheum; 2011 May; 63(5):1265-73. PubMed ID: 21305530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of power Doppler ultrasound for prediction of re-therapy with rituximab in rheumatoid arthritis: a prospective study of longstanding rheumatoid arthritis patients.
    Reiche BE; Ohrndorf S; Feist E; Messerschmidt J; Burmester GR; Backhaus M
    Arthritis Care Res (Hoboken); 2014 Feb; 66(2):204-16. PubMed ID: 23925935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misclassification of disease activity when assessing individual patients with early rheumatoid arthritis using disease activity indices that do not include joints of feet.
    Bakker MF; Jacobs JW; Kruize AA; van der Veen MJ; van Booma-Frankfort C; Vreugdenhil SA; Bijlsma JW; Lafeber FP; Welsing PM
    Ann Rheum Dis; 2012 Jun; 71(6):830-5. PubMed ID: 22128075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression.
    Syversen SW; Goll GL; van der Heijde D; Landewé R; Gaarder PI; Odegård S; Haavardsholm EA; Kvien TK
    J Rheumatol; 2009 Feb; 36(2):266-72. PubMed ID: 19132792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis.
    Plant MJ; Williams AL; O'Sullivan MM; Lewis PA; Coles EC; Jessop JD
    Arthritis Rheum; 2000 Jul; 43(7):1473-7. PubMed ID: 10902748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.
    Smolen JS; Van Der Heijde DM; St Clair EW; Emery P; Bathon JM; Keystone E; Maini RN; Kalden JR; Schiff M; Baker D; Han C; Han J; Bala M;
    Arthritis Rheum; 2006 Mar; 54(3):702-10. PubMed ID: 16508926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis.
    Meyer O; Nicaise-Roland P; Santos MD; Labarre C; Dougados M; Goupille P; Cantagrel A; Sibilia J; Combe B
    Arthritis Res Ther; 2006; 8(2):R40. PubMed ID: 16469118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximab.
    Klarenbeek NB; Güler-Yüksel M; van der Heijde DM; Hulsmans HM; Kerstens PJ; Molenaar TH; de Sonnaville PB; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2010 Dec; 69(12):2107-13. PubMed ID: 20610442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classifying structural joint damage in rheumatoid arthritis as progressive or nonprogressive using a composite definition of joint radiographic change: a preliminary proposal.
    Paulus HE; Oh M; Sharp JT; Gold RH; Wong WK; Park GS; Bulpitt KJ;
    Arthritis Rheum; 2004 Apr; 50(4):1083-96. PubMed ID: 15077290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do radiographic joint damage and disease activity influence functional disability through different mechanisms? Direct and indirect effects of disease activity in established rheumatoid arthritis.
    Nair SC; Bijlsma JW; van der Werf JH; van der Veen MJ; Linn-Rasker SP; Vreugdenhil S; Lafeber FP; Welsing PM
    J Rheumatol; 2013 Sep; 40(9):1505-12. PubMed ID: 23818710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eficiency of different doses of rituximab in rheumatoid arthritis.
    Mena-Vázquez N; Manrique-Arija S; Ureña-Garnica I; Romero-Barco CM; Jiménez-Núñez FG; Coret V; Irigoyen-Oyarzábal MV; Fernández-Nebro A
    Reumatol Clin; 2016; 12(3):139-45. PubMed ID: 26458761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum pyridinoline levels and prediction of severity of joint destruction in rheumatoid arthritis.
    Krabben A; Knevel R; Huizinga TW; Cavet G; van der Helm-van Mil AH
    J Rheumatol; 2013 Aug; 40(8):1303-6. PubMed ID: 23729802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The smallest detectable difference and sensitivity to change of magnetic resonance imaging and radiographic scoring of structural joint damage in rheumatoid arthritis finger, wrist, and toe joints: a comparison of the OMERACT rheumatoid arthritis magnetic resonance imaging score applied to different joint combinations and the Sharp/van der Heijde radiographic score.
    Ejbjerg BJ; Vestergaard A; Jacobsen S; Thomsen HS; Østergaard M
    Arthritis Rheum; 2005 Aug; 52(8):2300-6. PubMed ID: 16052593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference.
    Bruynesteyn K; van der Heijde D; Boers M; Saudan A; Peloso P; Paulus H; Houben H; Griffiths B; Edmonds J; Bresnihan B; Boonen A; van der Linden S
    Arthritis Rheum; 2002 Apr; 46(4):913-20. PubMed ID: 11953967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of a ceiling effect on the assessment of radiographic progression in rheumatoid arthritis during the first 6 years of disease.
    Kuper IH; van Leeuwen MA; van Riel PL; Sluiter WJ; Houtman NM; Cats HA; van Rijswijk MH
    J Rheumatol; 1999 Feb; 26(2):268-76. PubMed ID: 9972957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.